Li Zhao
Materials Science · The Ohio State University
Publications
59
Citations
3,580
Est. group size
~2
Recurring co-author estimate
Active years
29
Publishing since 1998
The bibliographic record attributed to this name spans a very wide range of biomedical topics, including cancer biology (leukemia, lymphoma, liver and pancreatic cancer), immunology, plant pathology, kinase-binding assays, and circadian biology in zebrafish, without a single unifying research theme. This pattern, combined with a low relevance-score match to the listed OpenAlex topics, suggests the publication list may represent contributions from multiple researchers sharing the same name rather than one coherent research program. Prospective students should treat this profile with caution and seek clarification on which specific line of work, if any, belongs to this individual.
Output has been irregular over the last decade, rising to about five papers per year around 2022-2023 before dropping sharply in 2024-2025, with an uptick in 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Quantification of Binding of Small Molecules to Native Kinases by Flow Cytometry Reveals Divergence from Biochemical Affinities
Journal of the American Chemical Society · 2026
- Evolution of chronic lymphocytic leukemia after allogeneic stem cell transplant
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Clonal Origin of Therapy-Related Myeloid Neoplasms after Autologous Stem Cell Transplant
Blood · 2024
- Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula
Journal of Ethnopharmacology · 2023
- TFE3 nuclear expression as a novel biomarker of ovarian sclerosing stromal tumors and associated with its histological morphology
Journal of Ovarian Research · 2023
- P1330: CYTOREDUCTIVE CHEMOTHERAPY COULD ACCELERATE THE LOSS OF CLONAL DIVERSITY IN HEMATOPOIETIC STEM CELLS AND PROMOTES THE CONVERGENT EVOLUTION OF THERAPY-RELATED CLONAL HEMATOPOIESIS
HemaSphere · 2023
- Survival Benefit of Pembrolizumab for Patients With Pancreatic Adenocarcinoma: A Case Series
Journal of Medical Cases · 2022
- Immune scoring model based on immune cell infiltration to predict prognosis in diffuse large B‐cell lymphoma
Cancer · 2022
- The effector protein CgNLP1 of <i>Colletotrichum gloeosporioides</i> from <i>Hevea brasiliensis</i> disrupts nuclear localization of necrosis-induced transcription factor HbMYB8-like to suppress plant defense signaling
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- Editorial: Novel modalities in cancer diagnostics and therapeutics
Frontiers in Pharmacology · 2022
- Flow cytometry analysis of immune and glial cells in a trigeminal neuralgia rat model
Scientific Reports · 2021
- Editorial: New Technologies in Cancer Diagnostics and Therapeutics
Frontiers in Pharmacology · 2021
- Liver transplantation for liver cancer in the era of immunotherapy
DOAJ (DOAJ: Directory of Open Access Journals) · 2021
- Plumbagin inhibits proliferation and promotes apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inactivating PI3K/Akt/mTOR pathway
Animal Cells and Systems · 2020
- Genetic links between endometriosis and cancers in women
PeerJ · 2019
- Journal of the American Chemical Society×2
- DOAJ (DOAJ: Directory of Open Access Journals)×2
- Frontiers in Pharmacology×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Journal of Ethnopharmacology×1
- Genki Terashi
Materials Science · Purdue University West Lafayette
- Xusi Han
Materials Science · Purdue University West Lafayette
- Seema Nath
Materials Science · The Ohio State University
- Aloke Kumar Bera
Materials Science · Purdue University West Lafayette
- Jian Hu
Materials Science · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile